Amarin Corp Plcuk AMRN
NASDAQ AMRN
$14.09 +0.03 (+0.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amarin Corp Plcuk (AMRN) Long-Term Investments (2020 - 2023)

Amarin Corp Plc\Uk (AMRN) posted quarterly Long-Term Investments of $100000.0 for Q2 2023, down 99.12% year-over-year from $11.4 million in Q2 2022, and down 81.62% quarter-over-quarter from $544000.0 in Q1 2023.

Amarin Corp Plcuk (AMRN) Long-Term Investments (2020 - 2023) Analysis & Trends

Amarin Corp Plc\Uk (AMRN) has reported Long-Term Investments for 4 consecutive years, with $100000.0 the latest figure, recorded in Q2 2023.

  • In Q2 2023, Long-Term Investments fell 99.12% year-over-year to $100000.0; the TTM figure through Jun 2023 stood at $100000.0 (down 99.12% YoY), while the FY2022 annual figure was $1.3 million, down 96.36% from the prior year.
  • Long-Term Investments slipped to $100000.0 in Q2 2023 per AMRN's latest filing, from $544000.0 in the prior quarter.
  • Across five years, Long-Term Investments topped out at $81.5 million in Q1 2020 and bottomed at $100000.0 in Q2 2023.
  • Historically, Long-Term Investments has averaged $29.0 million across 4 years, with a median of $25.4 million in 2021.
  • Annual changes were most pronounced in 2022 — Long-Term Investments rose 11.24% — and 2023, when it slumped 99.12%.
  • Amarin Corp Plc\Uk's Long-Term Investments stood at $62.5 million in 2020, then slumped by 43.98% to $35.0 million in 2021, then sank by 96.36% to $1.3 million in 2022, then sank by 92.16% to $100000.0 in 2023.
  • Business Quant data shows AMRN's Long-Term Investments at $100000.0 in Q2 2023, $544000.0 in Q1 2023, and $1.3 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 266.00 Mn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 297.00 Mn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 1.56 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 135.51 Mn
10 Amarin Corp Plcuk 5.86 Bn 5.54 Bn 14.99 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 100,000.00
Mar 31, 2023 544,000.00
Dec 31, 2022 1.28 Mn
Sep 30, 2022 2.30 Mn
Jun 30, 2022 11.40 Mn
Mar 31, 2022 26.70 Mn
Dec 31, 2021 35.00 Mn
Sep 30, 2021 38.80 Mn
Jun 30, 2021 14.20 Mn
Mar 31, 2021 24.00 Mn
Dec 31, 2020 62.47 Mn
Sep 30, 2020 46.10 Mn
Jun 30, 2020 61.04 Mn
Mar 31, 2020 81.52 Mn